Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Elsevier’s Scopus Connects with Brazil’s National Database of Research and Science Résumés

June 19, 2012

AMSTERDAM, June 19, 2012 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], a world-leading publisher of scientific,
technical and medical information products and services, announced that Scopus
[http://www.info.sciverse.com/scopus ], the world’s largest abstract and citation database
of peer-reviewed research literature, is interoperable with the Lattes Platform
[http://lattes.cnpq.br/english/index.htm ], Brazil’s national database for research and
science activity, through a newly developed application.

The new Curriculo Lattes Application
[http://www.applications.sciverse.com/action/appDetail/299875?zone=main&pageOrigin=appGallery&activity=display ]
links Scopus to the Lattes Platform providing easier access to the
extensive research author data contained in Curriculo Lattes
[http://lattes.cnpq.br/english/conteudo/aplataforma.htm ], a part of the Lattes Platform,
which contains the resumes of Brazilian researchers, students and technical professionals.

Developed using the Elsevier Application Framework, the Curriculo Lattes App will be
featured on each Scopus Author Details page. Currently 11,000 Brazilian authors in
Curriculo Lattes are mapped to matching Scopus author IDs allowing users to access
relevant profiles easily between the two databases. More Brazilian researchers will soon
be mapped in Scopus and added to the application.

“The link to Curriculo Lattes greatly enhances Brazil’s science research community by
allowing more efficiency, visibility, and connectivity amongst Brazilian researchers,”
said Dante Cid, Director South America, Elsevier Science & Technology. “It is a
significant step in our commitment to collaborate with Brazilian institutions to increase
the international visibility of their research output.”

About Scopus

Covering the world’s research literature, Scopus [http://www.info.scopus.com ] is the
largest abstract and citation database of peer-reviewed literature. Featuring smart tools
to track, analyze and visualize research, Scopus was designed and developed with input
from over 500 users and librarians internationally. Its unique database contains abstracts
and references from nearly 19,500 peer-reviewed journals from more than 5,000 publishers
worldwide, ensuring broad interdisciplinary coverage. Direct links to subscribed full-text
articles, library resources and other applications like reference management software,
make Scopus quicker, easier and more comprehensive to use than any other literature
research tool.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Catherine Gold
        Elsevier
        +1-212-462-1965
        c.gold@elsevier.com

SOURCE Elsevier


Source: PR Newswire